Conor A. Bradley

973 total citations
76 papers, 710 citations indexed

About

Conor A. Bradley is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Conor A. Bradley has authored 76 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 21 papers in Oncology and 16 papers in Immunology. Recurrent topics in Conor A. Bradley's work include Cancer Immunotherapy and Biomarkers (7 papers), Immune Cell Function and Interaction (7 papers) and Immune cells in cancer (7 papers). Conor A. Bradley is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Immune Cell Function and Interaction (7 papers) and Immune cells in cancer (7 papers). Conor A. Bradley collaborates with scholars based in United States, United Kingdom and Italy. Conor A. Bradley's co-authors include Patrick G. Johnston, Sandra Van Schaeybroeck, Manuel Salto‐Tellez, Mark Lawler, Hajrah Khawaja, Alberto Bardelli, Christian Rolfo, Pierre Laurent‐Puig, Josep Tabernero and Philip D. Dunne and has published in prestigious journals such as Nature reviews. Cancer, Nature Reviews Genetics and Nature Reviews Drug Discovery.

In The Last Decade

Conor A. Bradley

72 papers receiving 706 citations

Peers

Conor A. Bradley

MB

ONCOL

CR

PRM

PFM

Rifat Hasina United States

Dan G. Duda United States

Ming-Heng Wu Taiwan

Li‐Chin Yao United States

Fumie Omotehara Japan

Wensheng Qiu China

Lizhou Jia China

Keiji Tanese Japan

Franziska Arlt Germany

Rifat Hasina United States

Conor A. Bradley

612 ×1.9

MB

326 ×1.1

ONCOL

275 ×2.0

CR

218 ×1.8

PRM

75 ×0.7

PFM

Citations per year, relative to Conor A. Bradley Conor A. Bradley (= 1×) peers Rifat Hasina

Countries citing papers authored by Conor A. Bradley

Since Specialization

Citations

This map shows the geographic impact of Conor A. Bradley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conor A. Bradley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conor A. Bradley more than expected).

Fields of papers citing papers by Conor A. Bradley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conor A. Bradley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conor A. Bradley. The network helps show where Conor A. Bradley may publish in the future.

Co-authorship network of co-authors of Conor A. Bradley

This figure shows the co-authorship network connecting the top 25 collaborators of Conor A. Bradley. A scholar is included among the top collaborators of Conor A. Bradley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conor A. Bradley. Conor A. Bradley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Bradley, Conor A.. (2019). First antisense drug is approved with fleeting success. 4 indexed citations

2.

Bradley, Conor A.. (2019). Brain metastases respond to neratinib plus capecitabine. Nature Reviews Clinical Oncology. 16(6). 336–336. 4 indexed citations

3.

Bradley, Conor A.. (2019). 2019 ASCO Genitourinary Cancers Symposium. Nature Reviews Urology. 16(4). 207–207. 3 indexed citations

4.

Bradley, Conor A.. (2019). Urethral macrophages — a new HIV-1 reservoir. Nature Reviews Urology. 16(4). 205–205. 1 indexed citations

5.

Bradley, Conor A.. (2019). Tumour microbiome defines outcomes. Nature reviews. Cancer. 19(10). 545–545. 3 indexed citations

6.

Bradley, Conor A.. (2019). A statistical framework for rare disease diagnosis. Nature Reviews Genetics. 21(1). 2–3. 2 indexed citations

7.

Bradley, Conor A.. (2019). Single-cell genomics illuminates human forebrain development. Nature Reviews Genetics. 21(1). 2–3. 1 indexed citations

8.

Bradley, Conor A.. (2019). Prophylactic TNF blockade reduces autoimmune toxicity. Nature reviews. Cancer. 19(7). 364–364. 1 indexed citations

9.

Bradley, Conor A.. (2019). Pembrolizumab improves OS across PD-L1 subgroups. Nature Reviews Clinical Oncology. 16(7). 403–403. 6 indexed citations

10.

Bradley, Conor A.. (2019). Perioperative FLOT superior to ECF/X. Nature Reviews Clinical Oncology. 16(8). 465–465. 4 indexed citations

11.

Bradley, Conor A., Manuel Salto‐Tellez, Pierre Laurent‐Puig, et al.. (2018). Erratum: Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges. Nature Reviews Clinical Oncology. 15(3). 150–150. 13 indexed citations

12.

Bradley, Conor A.. (2018). ERCC2 mutations drive cisplatin sensitivity. Nature Reviews Urology. 16(2). 67–67. 1 indexed citations

13.

Bradley, Conor A.. (2018). Interfocal genomic heterogeneity uncovered. Nature Reviews Urology. 15(12). 726–726. 1 indexed citations

14.

Bradley, Conor A.. (2018). FGFR1 reprogrammes cell metabolism. Nature Reviews Urology. 15(9). 528–528. 1 indexed citations

15.

Bradley, Conor A.. (2018). Myeloid-derived IL-23 drives CRPC. Nature Reviews Urology. 15(9). 528–528. 2 indexed citations

16.

Bradley, Conor A.. (2018). IL-23 links glutamine addiction and immune function. Nature Reviews Urology. 15(12). 725–725. 3 indexed citations

17.

Bradley, Conor A.. (2018). Mirabegron and solifenacin for OAB. Nature Reviews Urology. 15(9). 526–526.

18.

Dunne, Philip D., Darragh G. McArt, Conor A. Bradley, et al.. (2016). Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer. Clinical Cancer Research. 22(16). 4095–4104. 103 indexed citations

19.

Bradley, Conor A., Joanna Majkut, Catherine Higgins, et al.. (2016). FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics. 15(10). 2432–2441. 19 indexed citations

20.

Dunne, Philip D., Sonali Dasgupta, Jaine K. Blayney, et al.. (2015). EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer. Clinical Cancer Research. 22(1). 230–242. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact